Craig C. Earle
#127,010
Most Influential Person Now
Craig C. Earle's AcademicInfluence.com Rankings
Craig C. Earlepsychology Degrees
Psychology
#2641
World Rank
#3049
Historical Rank
Clinical Psychology
#221
World Rank
#224
Historical Rank
Download Badge
Psychology
Why Is Craig C. Earle Influential?
(Suggest an Edit or Addition)Craig C. Earle's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers (2004) (912)
- Trends in the aggressiveness of cancer care near the end of life. (2004) (865)
- Health care costs in the last week of life: associations with end-of-life conversations. (2009) (841)
- Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? (2008) (783)
- Identifying potential indicators of the quality of end-of-life cancer care from administrative data. (2003) (701)
- Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients (2003) (533)
- Under use of necessary care among cancer survivors (2004) (433)
- Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. (2012) (418)
- Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. (1999) (407)
- The expanding role of primary care in cancer control. (2015) (399)
- Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. (2006) (390)
- Follow-up of patients with curatively resected colorectal cancer: a practice guideline (2003) (383)
- Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. (2011) (356)
- Evaluating claims-based indicators of the intensity of end-of-life cancer care. (2005) (329)
- Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. (2011) (319)
- Physician factors associated with discussions about end‐of‐life care (2010) (302)
- Systematic overview of cost-utility assessments in oncology. (2000) (295)
- Quality of non-breast cancer health maintenance among elderly breast cancer survivors. (2003) (283)
- End-of-Life Care Discussions Among Patients With Advanced Cancer (2012) (273)
- Comparisons of patient and physician expectations for cancer survivorship care. (2009) (273)
- The outcomes and costs of acute myeloid leukemia among the elderly. (2002) (269)
- Failing to plan is planning to fail: improving the quality of care with survivorship care plans. (2006) (268)
- Family Perspectives on Aggressive Cancer Care Near the End of Life. (2015) (259)
- Differences Between Primary Care Physicians’ and Oncologists’ Knowledge, Attitudes and Practices Regarding the Care of Cancer Survivors (2011) (255)
- Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. (2001) (254)
- Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. (2006) (250)
- Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. (2012) (246)
- Who gets chemotherapy for metastatic lung cancer? (2000) (231)
- The interface between primary and oncology specialty care: treatment through survivorship. (2010) (221)
- Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. (2006) (219)
- The effect of race on invasive staging and surgery in non-small-cell lung cancer. (2006) (209)
- Symptom burden and performance status in a population‐based cohort of ambulatory cancer patients (2010) (201)
- An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. (2002) (196)
- When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology. (2009) (180)
- Impact of referral patterns on the use of chemotherapy for lung cancer. (2002) (179)
- Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. (2006) (173)
- Racial and Ethnic Differences in End‐of‐Life Care in Fee‐for‐Service Medicare Beneficiaries with Advanced Cancer (2009) (171)
- How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. (2010) (167)
- Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. (2009) (152)
- Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology (2006) (148)
- Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. (2012) (139)
- Preventive care for colorectal cancer survivors: a 5-year longitudinal study. (2008) (139)
- Comparing Care for Breast Cancer Survivors to Non-Cancer Controls: A Five-Year Longitudinal Study (2009) (138)
- Does reimbursement influence chemotherapy treatment for cancer patients? (2006) (138)
- Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence (2012) (138)
- The effect on survival of continuing chemotherapy to near death (2011) (137)
- Trends in Follow-up and Preventive Care for Colorectal Cancer Survivors (2008) (129)
- Patient and treatment factors associated with complications after prostate brachytherapy. (2006) (124)
- Discussions with physicians about hospice among patients with metastatic lung cancer. (2009) (121)
- Looking back from death: the value of retrospective studies of end-of-life care. (2006) (118)
- Identifying Cancer Relapse Using SEER-Medicare Data (2002) (115)
- Impact of aggressive management and palliative care on cancer costs in the final month of life (2015) (114)
- Measuring Complications of Cancer Treatment Using the SEER-Medicare Data (2002) (113)
- Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis (2010) (112)
- Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. (2006) (111)
- Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. (2011) (110)
- Toward population‐based indicators of quality end‐of‐life care (2008) (109)
- Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer. (2004) (108)
- The determinants of home and nursing home death: a systematic review and meta-analysis (2016) (107)
- Racial Differences in Cancer Specialist Consultation, Treatment, and Outcomes for Locoregional Pancreatic Adenocarcinoma (2009) (105)
- Economic decision analysis model of screening for lung cancer. (2001) (104)
- Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. (2003) (104)
- Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists (2013) (104)
- Racial segregation and disparities in breast cancer care and mortality (2008) (102)
- Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. (2007) (101)
- Physician roles in the cancer-related follow-up care of cancer survivors. (2013) (100)
- A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors. (2006) (97)
- Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. (2013) (95)
- Hospice care and survival among elderly patients with lung cancer. (2011) (95)
- Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data. (2009) (95)
- Barriers to Quality End-of-Life Care for Patients With Blood Cancers. (2016) (94)
- Etiology of Delays in the Initiation of Adjuvant Chemotherapy and Their Impact on Outcomes for Stage II and III Rectal Cancer (2009) (94)
- A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma (2002) (94)
- Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. (2000) (92)
- Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. (2005) (91)
- A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma (2002) (91)
- A Phase II Trial of Irinotecan and Cisplatin in Patients with Metastatic Neuroendocrine Tumors (2006) (88)
- Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344) (2006) (87)
- Racial Segregation and Disparities in Cancer Stage for Seniors (2008) (86)
- Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. (2005) (85)
- Quality of Care for Older Patients With Cancer in the Veterans Health Administration Versus the Private Sector (2011) (84)
- Outcomes research in oncology: history, conceptual framework, and trends in the literature. (2000) (84)
- Trends in the Treatment of Acute Myeloid Leukaemia in the Elderly (2005) (84)
- Hospital characteristics, clinical severity, and outcomes for surgical oncology patients. (2010) (83)
- MANAGING THE TRANSITION FROM CANCER PATIENT TO CANCER SURVIVOR (2007) (83)
- Cancer survivorship care: don't let the perfect be the enemy of the good. (2012) (82)
- Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. (2013) (82)
- Advancing performance measurement in oncology: quality oncology practice initiative participation and quality outcomes. (2011) (81)
- Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. (2008) (80)
- The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. (2004) (80)
- End‐of‐life care for older cancer patients in the Veterans Health Administration versus the private sector (2010) (76)
- Real‐world chemotherapy treatment patterns in metastatic non–small cell lung cancer: Are patients undertreated? (2015) (76)
- Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. (2013) (76)
- Employment among survivors of lung cancer and colorectal cancer. (2010) (75)
- Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy? (2015) (72)
- Lower Use of Hospice by Cancer Patients who Live in Minority Versus White Areas (2007) (70)
- Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial. (2021) (70)
- Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. (2012) (68)
- Disparities in hospice care among older women dying with ovarian cancer. (2012) (68)
- Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer (2007) (67)
- The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study. (2016) (66)
- Do unto others... (2006) (66)
- Influenza vaccination in elderly patients with advanced colorectal cancer. (2003) (64)
- Breast cancer survivors' perceptions of survivorship care options. (2012) (64)
- Survivorship services for adult cancer populations: a pan-Canadian guideline. (2011) (64)
- Long term care planning for cancer survivors: a health services research agenda (2007) (63)
- Regional variation in cancer‐directed surgery and mortality among women with epithelial ovarian cancer in the medicare population (2010) (62)
- End-of-life care for older patients with ovarian cancer is intensive despite high rates of hospice use. (2014) (62)
- An Assessment of Methods to Combine Published Survival Curves (2000) (61)
- Health care costs associated with hepatocellular carcinoma: A population‐based study (2013) (60)
- How does initial treatment choice affect short‐term and long‐term costs for clinically localized prostate cancer? (2010) (60)
- Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer. (2011) (60)
- Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer (2008) (59)
- Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States. (2009) (58)
- Diagnostic delay and complications for older adults with multiple myeloma (2009) (57)
- Health system costs for stage-specific breast cancer: a population-based approach. (2014) (57)
- Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer. (2011) (56)
- Why are patients with blood cancers more likely to die without hospice? (2017) (55)
- Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. (2018) (55)
- Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States (2010) (55)
- Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America (2012) (54)
- Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. (2009) (54)
- A Phase II Trial of Irinotecan in Patients with Previously Untreated Advanced Esophageal and Gastric Adenocarcinoma (2005) (53)
- Preventive care in prostate cancer patients: following diagnosis and for five-year survivors (2011) (53)
- Association of area sociodemographic characteristics and capacity for treatment with disparities in colorectal cancer care and mortality (2011) (53)
- Patterns of care for radical prostatectomy in the United States from 2003 to 2005. (2008) (52)
- Oxaliplatin-induced Evan's syndrome (2001) (52)
- Marital status and survival following bladder cancer (2009) (52)
- Optimal Management of Gastric Cancer: Results From an International RAND/UCLA Expert Panel (2014) (52)
- Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. (2010) (50)
- Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. (2007) (50)
- Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. (2008) (50)
- Opioid prescription after pain assessment: a population-based cohort of elderly patients with cancer. (2012) (50)
- Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis (2019) (49)
- Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer. (2015) (49)
- Guidance for management of cancer surgery during the COVID-19 pandemic. (2020) (49)
- Predictors of and Trends in High-Intensity End-of-Life Care Among Children With Cancer: A Population-Based Study Using Health Services Data. (2016) (49)
- Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices. (2010) (48)
- Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care. (2015) (46)
- Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis (2009) (46)
- Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. (2013) (45)
- Vulnerable And Less Vulnerable Women In High-Deductible Health Plans Experienced Delayed Breast Cancer Care. (2019) (45)
- Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists. (2016) (44)
- Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results—Medicare data (2009) (42)
- Incidence of Diabetes in Colorectal Cancer Survivors. (2016) (42)
- Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer (2016) (41)
- Geographic variation in physicians' responses to a reimbursement change. (2011) (41)
- Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer. (2007) (41)
- Thymidylate Synthase Expression in Stage II and III Colon Cancer: A Retrospective Review (2001) (41)
- Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination (2015) (40)
- Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability. (2016) (40)
- Outcomes research in lung cancer. (2004) (40)
- The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy (2017) (39)
- Provider case volume and outcomes following prostate brachytherapy. (2009) (39)
- Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel. (2014) (38)
- It’s who you know: patient-sharing, quality, and costs of cancer survivorship care (2014) (37)
- Physicians’ Beliefs About Breast Cancer Surveillance Testing are Consistent With Test Overuse (2013) (36)
- CANADIAN CANCER RISK MANAGEMENT MODEL: EVALUATION OF CANCER CONTROL (2013) (36)
- Predictors of Specialized Pediatric Palliative Care Involvement and Impact on Patterns of End-of-Life Care in Children With Cancer. (2018) (36)
- Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. (2002) (36)
- Influence of Socioeconomic Status on Survival of Hepatocellular Carcinoma in the Ontario Population; A Population-Based Study, 1990–2009 (2012) (35)
- Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. (2006) (34)
- Influenza Vaccine Effectiveness Among Patients With Cancer: A Population-Based Study Using Health Administrative and Laboratory Testing Data From Ontario, Canada. (2019) (34)
- The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population‐based retrospective matched cohort analysis (2020) (34)
- Mental health service utilization among long-term cancer survivors (2007) (34)
- Cancer physicians' attitudes toward colorectal cancer follow-up. (2003) (34)
- Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer (2006) (31)
- A qualitative focus group study to identify the needs of survivors of stage II and III colorectal cancer (2016) (31)
- Journal of Clinical Oncology update on progress in cancer survivorship care and research. (2012) (31)
- The association of the palliative performance scale and hazard of death in an ambulatory cancer population. (2013) (30)
- Methodological Issues in the Use of Administrative Claims Data to Study Surveillance After Cancer Treatment (2002) (30)
- Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information. (2006) (27)
- Hepatobiliary cancers. Clinical practice guidelines in oncology. (2009) (26)
- Modeling the longitudinal transitions of performance status in cancer outpatients: time to discuss palliative care. (2013) (26)
- Delays in referral and diagnosis for chronic hematologic malignancies: A literature review (2008) (26)
- Measuring patient-reported outcomes to improve cancer care in Canada: an analysis of provincial survey data. (2018) (26)
- Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia (2011) (26)
- Cancer survivorship research and guidelines: maybe the cart should be beside the horse. (2007) (26)
- A population-based study of the epidemiology of pancreatic cancer: a brief report. (2015) (26)
- Impact of Standardized Edmonton Symptom Assessment System Use on Emergency Department Visits and Hospitalization: Results of a Population-Based Retrospective Matched Cohort Analysis. (2020) (25)
- Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer. (2008) (25)
- Surveillance after resection for colorectal cancer (2013) (25)
- Behavioral health services for women who have breast cancer. (2009) (25)
- Increasing participation in colorectal cancer screening: Results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders (2015) (25)
- Population-Level Symptom Assessment Following Pancreaticoduodenectomy for Adenocarcinoma. (2019) (25)
- Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405. (2015) (24)
- Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting (2017) (24)
- Treatment and outcomes of gastric cancer among United States‐born and foreign‐born Asians and Pacific Islanders (2009) (23)
- Adjuvant therapy for elderly patients with resected gastric adenocarcinoma (2012) (23)
- Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay. (2017) (23)
- Outcomes Assessment in Cancer: The science of quality-of-life measurement in lung cancer (2004) (23)
- Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer. (2007) (23)
- Association of local capacity for endoscopy with individual use of colorectal cancer screening and stage at diagnosis (2010) (22)
- Physician Agency and Competition: Evidence from a Major Change to Medicare Chemotherapy Reimbursement Policy (2013) (22)
- Impact of Immigration Status on Cancer Outcomes in Ontario, Canada. (2017) (22)
- Opioid Prescribing Among Cancer and Non-cancer Patients: Time Trend Analysis in the Elderly Using Administrative Data. (2017) (22)
- Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population‐based cohort study (2016) (22)
- Vasectomy and risk of prostate cancer: population based matched cohort study (2016) (22)
- Utilization and costs of home care for patients with colorectal cancer: a population-based study. (2014) (22)
- A Framework for Cancer Survivorship Research and Translation to Policy (2011) (22)
- Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States. (2009) (21)
- Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial (2019) (21)
- Incident Cancer Detection During the COVID-19 Pandemic. (2022) (21)
- Symptom clusters in a population-based ambulatory cancer cohort validated using bootstrap methods. (2012) (21)
- Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study (2016) (21)
- Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer (2007) (21)
- Trends in healthcare utilization among older Americans with colorectal cancer: A retrospective database analysis (2009) (20)
- Treatment Patterns, Outcomes and Costs Among Elderly Patients with Chronic Myeloid Leukaemia (2004) (20)
- Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study (2015) (19)
- Physician Agency and Patient Survival. (2017) (19)
- Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions. (2019) (19)
- Integration of patient-reported outcomes (PROs) for personalized symptom management in “real-world” oncology practices: a population-based cohort comparison study of impact on healthcare utilization (2020) (18)
- Phase-specific healthcare costs of cervical cancer: estimates from a population-based study. (2016) (18)
- Integrating early palliative care into routine practice for patients with cancer: A mixed methods evaluation of the INTEGRATE Project (2019) (18)
- Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans (2018) (18)
- Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013 (2018) (17)
- Population-based home care services in breast cancer: utilization and costs. (2012) (17)
- Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal cancer. (2006) (17)
- Referrals for suspected hematologic malignancy: A survey of primary care physicians (2012) (17)
- Days at Home in the Last 6 Months of Life: A Patient-Determined Quality Indicator for Cancer Care. (2019) (16)
- Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis (2019) (16)
- Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer. (2014) (16)
- Factors Associated With Opioid Use in Long-term Cancer Survivors. (2019) (16)
- The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study (2017) (16)
- Repeated assessments of symptom severity improve predictions for risk of death among patients with cancer. (2014) (16)
- Radiation costing methods: a systematic review. (2016) (16)
- Understanding Long-Term Cancer Survivors’ Preferences for Ongoing Medical Care (2019) (16)
- Cost‐effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person‐level data in a Canadian setting (2017) (16)
- Access to Palliative Care for Cancer Patients Living in a Northern and Rural Environment in Ontario, Canada: The Effects of Geographic Region and Rurality on End-of-Life Care in a Population-Based Decedent Cancer Cohort (2019) (15)
- The treatment of locally advanced pancreatic cancer: a practice guideline. (2003) (15)
- How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists. (2019) (15)
- Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer (2020) (14)
- Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer. (1997) (14)
- Effective Use of Advanced Practice Nurses in the Delivery of Adult Cancer Services in Ontario (2015) (14)
- Patterns of care studies: creating "an environment of watchful concern". (2003) (14)
- Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study (2018) (13)
- Does early palliative identification improve the use of palliative care services? (2020) (13)
- The Combination of Capecitabine and Thalidomide in Previously Treated, Refractory Metastatic Colorectal Cancer (2006) (13)
- Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies (2020) (13)
- Gender disparities in bladder cancer survival: An assessment of socio-demographic factors. (2006) (13)
- Factors related to second cancer screening practice in disease-free cervical cancer survivors (2009) (13)
- Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study. (2015) (12)
- Associations between advanced cancer patients' end-of-life conversations and cost experiences in the final week of life (2008) (12)
- The evaluation of cancer control interventions in lung cancer using the Canadian Cancer Risk Management Model (2012) (12)
- Examination of Health System Resources and Costs Associated With Transitioning Cancer Survivors to Primary Care: A Propensity-Score-Matched Cohort Study. (2018) (12)
- Prevalence of Inappropriateness of Parenteral Vitamin B12 Administration in Ontario, Canada. (2019) (12)
- Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer (2018) (12)
- Breast Density and Risk of Interval Cancers: The Effect of Annual Versus Biennial Screening Mammography Policies in Canada. (2021) (12)
- What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel. (2013) (12)
- Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada (2019) (12)
- Predictors of adjuvant treatment for pancreatic adenocarcinoma at the population level. (2016) (12)
- Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study (2017) (11)
- A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer. (1998) (11)
- Quality of life drives patients’ preferences for secondary findings from genomic sequencing (2020) (11)
- Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy? (2010) (11)
- Lung cancer treatment costs, including patient responsibility, by stage of disease and treatment modality, 1992–2003 (2011) (11)
- The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care (2021) (11)
- Health system costs for cancer medications and radiation treatment in Ontario for the 4 most common cancers: a retrospective cohort study. (2020) (11)
- Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial (2021) (11)
- Advancing performance measurement in oncology. (2011) (11)
- The Choosing Wisely Canada cancer initiative. (2014) (11)
- A phase II study of docetaxel in combination with ZD1839 (gefitinib) in previously treated patients with metastatic pancreatic cancer (2007) (11)
- Erratum: Progress for resectable cancer?: A population‐based assessment of US practices (2010) (11)
- Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer. (2006) (11)
- Is Performance Status Associated with Symptom Scores? (2014) (10)
- Are We Choosing Wisely in Lymphoma? Excessive Use of Surveillance CT Imaging in Patients With Diffuse Large B‐cell Lymphoma (DLBCL) in Long‐term Remission (2018) (10)
- Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada (2020) (10)
- Surveillance patterns after curative-intent colorectal cancer surgery in Ontario. (2014) (10)
- Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer (2017) (10)
- End-of-life home care utilization and costs in patients with advanced colorectal cancer. (2014) (10)
- Two schedules of second‐line irinotecan for metastatic colon carcinoma (2004) (10)
- Meeting the 12 lymph nodes (LN) benchmark in colorectal cancer surgery: A comparison of NCCN and SEER data (2007) (10)
- Moving toward the elimination of cervical cancer: modelling the health and economic benefits of increasing uptake of human papillomavirus vaccines. (2019) (10)
- The impact of routine ESAS use on overall survival: Results of a population-based retrospective matched cohort analysis. (2019) (10)
- Role of comparative effectiveness research in cancer funding decisions in Ontario, Canada. (2012) (9)
- A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab (2018) (9)
- Closing the personalized medicine information gap: HER2 test documentation practice. (2013) (9)
- Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002-2009: a population-based cohort study. (2016) (9)
- A reader's guide to the evaluation of screening studies. (1996) (9)
- Material deprivation and access to cancer care in a universal health care system (2020) (9)
- Evidence-based medicine: a cup half full or half empty? (1999) (9)
- Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol (2019) (9)
- Lifesaving cancer surgeries need to be managed appropriately during the COVID-19 pandemic. (2020) (9)
- Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer. (2004) (9)
- Value assessment of oncology drugs using a weighted criterion‐based approach (2019) (9)
- Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes (2020) (9)
- Simulating results from trials of sigmoidoscopy screening using the OncoSim microsimulation model (2017) (8)
- Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer. (2022) (8)
- Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces (2021) (8)
- Phase II study of pemetrexed in patients with advanced neuroendocrine tumors (2010) (8)
- Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer System (2018) (8)
- Cancer outcomes in low-income elders: is there an advantage to being on Medicaid? (2012) (8)
- What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea? (2009) (8)
- Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugs (2019) (7)
- Evaluating the impact of survivorship models on health system resources and costs. (2018) (7)
- Patient surveillance after cancer treatment (2013) (7)
- Benefits of High-Volume Medical Oncology Care for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis. (2020) (7)
- The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis. (2020) (7)
- Projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for Canada using the OncoSim microsimulation model (2017) (7)
- The Effect of Vasectomy Reversal on Prostate Cancer Risk: International Meta‐Analysis of 684,660 Vasectomized Men (2018) (7)
- Frequency of non-cancer-related pain in patients with cancer. (2013) (7)
- Phase II study of FOLFOX, bevacizumab and erlotinib as initial therapy for patients with metastatic colorectal cancer (MCRC). (2006) (7)
- Capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer (2004) (7)
- High-Cost Patients and Preventable Spending: A Population-Based Study. (2020) (7)
- Management of screen-detected lung nodules: A Canadian partnership against cancer guidance document (2020) (7)
- Cancer stage comparison between dual Medicare-Medicaid eligibles using Medicaid as a supplemental health insurance program and low-income nonduals. (2011) (6)
- Comparison of Opioid Prescribing Among Cancer and Noncancer Patients Aged 18-64: Analysis Using Administrative Data. (2018) (6)
- The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study. (2017) (6)
- Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada (2020) (6)
- Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer (2016) (6)
- Resource utilization and disaggregated cost analysis for initial treatment of melanoma (2017) (6)
- Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario (2015) (6)
- Impact of comprehensive hospice palliative care on end-of-life care: a propensity-score-matched retrospective observational study. (2019) (6)
- Caregiver bereavement outcomes in advanced cancer: associations with quality of death and patient age (2021) (6)
- A Phase II Study of Modified deGramont 5-Fluorouracil, Leucovorin, and Oxaliplatin in Previously Treated Patients with Metastatic Colorectal Cancer (2003) (6)
- Erratum: Clinical benefits of a multivariate prediction model for bladder cancer: A decision analytic approach (Cancer (2009) 115 (5460-5469)) (2011) (6)
- Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses? (2019) (6)
- Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial Response (2020) (6)
- Symptom Burden of Nonresected Pancreatic Adenocarcinoma (2020) (6)
- Surveillance after Primary Therapy (2007) (6)
- The Survivorship Care Plan: What, Why, How, and for Whom (2007) (6)
- Symptom trajectories and predictors of severe symptoms in pancreatic adenocarcinoma at the end-of-life: a population based analysis of 2,538 patients. (2019) (6)
- Metastatic NSCLC: Treatment patterns, outcomes, and costs of newer agents. (2012) (5)
- Outcomes for hematologic malignancies in the Nurses’ Health Study (NHS) as compared to the Surveillance, Epidemiology, and End Results (SEER) program (2007) (5)
- Population-based utilization of radiation therapy by a Canadian breast cancer cohort. (2014) (5)
- It takes a village. (2012) (5)
- Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces. (2021) (5)
- Evaluating end of life care: The Quality Oncology Practice Initiative (QOPI) experience. (2006) (5)
- The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection. (2016) (5)
- Progress for resectable cancer? (2010) (5)
- Cetuximab plus irinotecan versus panitumumab in patients with refractory metastatic colorectal cancer in Ontario, Canada (2017) (5)
- Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes (2018) (5)
- The north-south and east-west gradient in colorectal cancer risk: a look at the distribution of modifiable risk factors and incidence across Canada. (2018) (5)
- Ontario Cancer Data Linkage Project: "cd-link". (2014) (5)
- The Validity of Using Health Administrative Data To Identify the Involvement of Specialized Pediatric Palliative Care Teams in Children with Cancer in Ontario, Canada. (2017) (4)
- A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer (2013) (4)
- Reply to U. Tirelli et al. (2014) (4)
- Real‐world, population‐based cohort study of toxicity and resource utilization of second‐line ipilimumab for metastatic melanoma in Ontario, Canada (2020) (4)
- Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia. (2002) (4)
- Population‐based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma (2018) (4)
- The generation of two specific cancer costing algorithms using Ontario administrative databases. (2019) (4)
- Building capacity for palliative care delivery in primary care settings (2021) (4)
- Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+) (2021) (4)
- Comparative Effectiveness and Safety of Pertuzumab and Trastuzumab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy for Treatment of Metastatic Breast Cancer (2022) (4)
- Variation in receipt of therapy and survival with provider volume for medical oncology in non-curative esophago-gastric cancer: a population-based analysis (2019) (4)
- Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the ‘real-world’ (2020) (4)
- Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program (2009) (4)
- Characteristics and Correlates of Increasing Use of Surgery in Taiwanese Cancer Patients’ Last Month of Life, 2001–2010 (2016) (4)
- The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada. (2020) (4)
- Predictors of Diagnosis Delay and Complications for Newly-Diagnosed Myeloma Patients. (2007) (3)
- Impact of Geography on Care Delivery and Survival for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis. (2020) (3)
- Impact of physician and center case volume on the adequacy of cardiac monitoring during adjuvant trastuzumab in breast cancer. (2013) (3)
- Cancer Survivorship: Monitoring the Long-Term and Late Effects of Treatment (2013) (3)
- Relationship Between Quality of Comorbid Condition Care and Costs for Cancer Survivors. (2016) (3)
- Long-term risk of heart failure associated with adjuvant trastuzumab in breast cancer patients. (2014) (3)
- Corrigendum to “Disparities in hospice care among older women dying with ovarian cancer” [Gynecologic Oncology 125 (2012) 14–18] (2012) (3)
- High-Intensity vs Low-Intensity Knowledge Translation Interventions for Surgeons and Their Association With Process and Outcome Measures Among Patients Undergoing Rectal Cancer Surgery (2021) (3)
- The impact of routine ESAS use on receiving palliative care services: Results of a population-based retrospective matched cohort analysis. (2018) (3)
- The journey from cancer patient to cancer survivor: A 5-year longitudinal study (2007) (3)
- Income and outcome in myelodysplastic syndrome: the prognostic impact of SES in a single-payer system. (2013) (3)
- Effect of surgeon specialty on outcomes for ovarian cancer. (2004) (3)
- Pan-Canadian standards for cancer surgery (2019) (3)
- Economic Analysis of Adjuvant Chemoradiotherapy Compared with Chemotherapy in Resected Pancreas Cancer (2019) (3)
- Quality indicators for end-of-life breast cancer care: Testing the use of administrative databases. (2006) (3)
- Mental health services use by melanoma patients receiving adjuvant interferon: association of pre-treatment mental health care with early discontinuation. (2017) (3)
- Acute care utilization (ACU) among women receiving adjuvant chemotherapy for early breast cancer (EBC). (2012) (3)
- Population‐based study of the prevalence and management of self‐reported high pain scores in patients with non‐resected pancreatic adenocarcinoma (2019) (3)
- Generating Costing Algorithms For Oncology Drugs Using Administrative Databases. (2015) (3)
- Operationalizing Outpatient Palliative Care Referral Criteria in Lung Cancer Patients: A Population-Based Cohort Study Using Health Administrative Data. (2020) (3)
- Has Province-Wide Symptom Screening Changed Opioid Prescribing Rates in Older Patients With Cancer? (2017) (3)
- Initiation of Chemotherapy in Cancer Patients with Poor Performance Status: A Population-Based Analysis (2014) (3)
- Measuring Quality of End-of-Life Care for Blood Cancers: A National Survey of Hematologic Oncologists (2015) (2)
- Are We Choosing Surveillance Imaging in Gastric and Pancreatic Cancers Wisely? A Population-Based Study (2019) (2)
- How often are opioids prescribed for cancer patients reporting pain? Results of a population-based analysis. (2011) (2)
- High Healthcare Utilization and Costs in Patients with Higher-Risk MDS/Low Blast Count AML Treated with Azacitidine in Ontario, Canada (2018) (2)
- Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapy. (2020) (2)
- Variable participation of knowledge users in cancer health services research: results of a multiple case study (2018) (2)
- Does routine symptom screening with the Edmonton Symptom Assessment System (ESAS) decrease emergency department visits in breast cancer patients undergoing adjuvant chemotherapy (2014) (2)
- Early palliative care and quality of dying and death in patients with advanced cancer (2021) (2)
- Sensitivity and specificity of self-reported cancer history compared to cancer registry. (2017) (2)
- Assessing the Impact of the COVID-19 Pandemic on Emergency Department Use for Patients Undergoing Cancer-Directed Surgeries (2022) (2)
- Comparative effectiveness and safety of the implementation of universal public funding of FOLFIRINOX (FFX) and gemcitabine (G) + nab-paclitaxel (GnP) in advanced pancreatic cancer (APC): A population-based study. (2018) (2)
- 216 Increasing Participation in Colorectal Cancer Screening: Results From a Randomized Trial of Directly Mailed FOBT Kits in a Hard to Reach Population (2013) (2)
- Barriers in providing breast and colorectal cancer survivorship care: Perceptions of U.S. primary care physicians (PCPs) and medical oncologists (MOs). (2011) (2)
- The impact of tumor histology on survival among elderly chemotherapy-treated patients with stage IIIB/IV NSCLC (2008) (2)
- Quality of Care (2007) (2)
- The cost of chemotherapy administration: A systematic review and meta-analysis. (2020) (2)
- Excess lifetime costs associated with colorectal cancer among elderly Medicare beneficiaries: Evidence from SEER-Medicare data (2008) (2)
- Abstract P5-18-14: Cardiac monitoring during adjuvant trastuzumab therapy for breast cancer (2012) (2)
- Quality indicators for end-of-life breast cancer care: Is there agreement between stakeholder groups? (2006) (2)
- Timeliness and Modality of Treatment for New Cancer Diagnoses During the COVID-19 Pandemic in Canada (2023) (2)
- Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast-Count Acute Myeloid Leukemia. (2020) (2)
- Impact of mortality due to malignant melanoma versus other cancers (2008) (2)
- Costs of treatments for local/regional prostate cancer. (2009) (2)
- Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic? (2022) (2)
- An evaluation of the breast cancer Well Follow-up Care Initiative using administrative databases: A new model of analysis. (2017) (2)
- A comparison of primary care providers’ and oncologists’ preferences for different models of cancer survivorship care. (2012) (2)
- Population-based health care cost estimates related to breast cancer by staging. (2011) (2)
- A phase II study of pemetrexed in patients (pts) with advanced neuroendocrine tumors (NETs) (2007) (2)
- The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer (2021) (2)
- PCN72 THE IMPACT OF INITIAL TREATMENT CHOICE AND DISEASE PROGRESSION ON THE ECONOMIC BURDEN OF PATIENTS AND THEIR CAREGIVERS—A LONGITUDINAL STUDY OF STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC) (2008) (2)
- 587PSurvival by sidedness of metastatic colorectal cancer (mCRC) treated with epidermal growth factor receptor antibodies (EGFR-Ab) in the refractory setting: A population-based study of 1509 patients (2017) (2)
- Impact of center case volume on cardiotoxicity during adjuvant trastuzumab in breast cancer. (2013) (2)
- 90 Comparison of the costs, toxicities, and inconvenience of different chemotherapy regimens for advanced non-small cell lung cancer (1997) (2)
- Economic impacts of care by high-volume providers for non-curative esophagogastric cancer: a population-based analysis (2019) (2)
- Is more intensive surveillance really a good idea for high-risk patients with colorectal cancer? (2014) (2)
- Capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer. (2004) (1)
- 165 : Response to Clinical Trial Information: Use of Radiation Therapy After Mastectomy between 1991-1999 in Elderly Women (2006) (1)
- Survival and cost associated with chemotherapy and chemoradiotherapy among resected pancreas cancer patients. (2019) (1)
- Adjuvant taxane therapy for early-stage breast cancer: A real-world comparison of chemotherapy regimens in Ontario. (2014) (1)
- Consistency in regional trends of aggressiveness in cancer care near the end of life for elderly Americans, 1991-2000. (2006) (1)
- Transforming Canada's role in global cancer control. (2021) (1)
- Can administrative data improve the performance of clinical trial economic analyses? (2018) (1)
- The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes (2021) (1)
- Predictors of specialized pediatric palliative care involvement and impact on patterns of end-of-life care in children with cancer: A population-based study. (2017) (1)
- Quality of care for comorbid conditions during the transition to survivorship. (2011) (1)
- Identifying P otential I ndicators o f t he Q uality o f E nd-of-Life Cancer C are F rom A dministrative D ata (2003) (1)
- Do patient-reported symptoms predict for emergency department visits? A population-based analysis. (2012) (1)
- Cost-effectiveness of computerized tomography screening for lung cancer in Hodgkin’s disease survivors (2003) (1)
- Ontario's approach to tackling drug funding sustainability. (2016) (1)
- Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada. (2020) (1)
- Demographic characteristics and cost of treatment among oncology patients in a publicly funded system, the Ontario Trillium Drug Program: a retrospective cohort study. (2019) (1)
- Undertreatment of noncurative pancreatic adenocarcinoma?: A population-based analysis of patterns of care. (2019) (1)
- Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake. (2022) (1)
- Monitoring acute care utilization (ACU) during adjuvant chemotherapy for early breast cancer (EBC) as a measure of quality. (2012) (1)
- Provider-volume associated with variable receipt of therapy and outcomes for noncurative pancreas adenocarcinoma: A population-based analysis. (2019) (1)
- Reply to C.B. Simone II (2012) (1)
- Improving access to cancer care together with Indigenous peoples (2018) (1)
- PCN39 DIFFERENCES IN COLORECTAL CANCER TREATMENT COSTS BYTREATMENT PHASE, CANCER SITE, AND STAGE AT DIAGNOSIS: EVIDENCE FROM LINKED SEER-MEDICARE DATA (2008) (1)
- Trends in stage distribution and survival among elderly colorectal cancer patients in the U.S. (2008) (1)
- UTILIZATION OF PHARMACOTHERAPY FOR ERECTILE DYSFUNCTION FOLLOWING SURGERY FOR PROSTATE CANCER (2008) (1)
- Out-of-pocket costs (OPC) and time costs (TC) for patients with stage IV non-small cell lung cancer (NSCLC) and their caregivers. (2004) (1)
- Driving quality improvement with public reporting: Use of imaging tests outside guidelines for early-stage breast cancer in Ontario. (2017) (1)
- Influenza vaccine effectiveness among cancer patients: A population-based study using health administrative and laboratory testing data from Ontario, Canada. (2018) (1)
- Outcomes of FOLFIRINOX (FFX) and gemcitabine+nab-paclitaxel (GnP) in initially unresectable locally advanced pancreatic cancer (uLAPC): A population-based study. (2017) (1)
- Reply to D.J. Brenner et al (2011) (1)
- Preventive care for breast cancer survivors versus controls: Changes between 1998 and 2002. (2008) (1)
- P-65. Anxiety over Breast Cancer: A Population Survey (1998) (1)
- Lessons learned from a cancer knowledge translation grants program: results of an evaluation. (2019) (1)
- PCN31 A PROBABILISTIC DECISION MODEL TO GUIDE OPTIMAL HEALTH POLICY DECISIONS FOR LUNG CANCER SCREENING (2008) (1)
- Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis (2022) (1)
- Claims/utilization-based intensity of end-of-life (EOL) cancer care in integrated health systems (IHS). (2012) (1)
- Adherence to human epidermal growth factor receptor-2 testing and adjuvant trastuzumab treatment guidelines in Ontario (2020) (1)
- Geographic Variation in Colorectal Cancer Incidence and the Disparities in the Prevalence of Modifiable Risk Factors Across Canada (2018) (1)
- Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada (2020) (1)
- Chemotherapy-related serious adverse events and health care expenditures among commercially insured women with breast cancer (2005) (1)
- Population Based Utilization of Radiation Therapy by a Canadian Breast Cancer Cohort (2013) (1)
- A phase II study of gemcitabine (G), bevacizumab (B), and erlotinib (E) in locally advanced (LAPC) and metastatic adenocarcinoma (MPC) of the pancreas (2008) (1)
- Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. (2006) (1)
- The cost of chemotherapy administration: a systematic review and meta-analysis (2021) (1)
- Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in Canada (2021) (1)
- Assessing the Impact of Early Identification of Patients Appropriate for Palliative Care on Resource Use and Costs in the Final Month of Life. (2020) (1)
- Timeliness of end-of-life (EOL) discussions for blood cancers: A national survey of hematologic oncologists. (2015) (1)
- The effect of race on recommendation and acceptance of surgical resection for non-metastatic non-small cell lung cancer (NSCLC). (2004) (0)
- Factors associated with the duration of treatment with palliative external beam radiation therapy among patients with metastatic non-small cell lung cancer (2003) (0)
- CN1 TRENDS IN TREATMENT AMONG ELDERLY COLORECTAL CANCER PATIENTS IN THE US: EVIDENCE FROM LINKED SEER-MEDICARE DATA (2008) (0)
- The cost of complications after pancreaticoduodenectomy: a population-based analysis (2017) (0)
- Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol (2019) (0)
- Figure 6.2, Trends in Age-Standardized Incidence and Mortality of Colorectal Cancer Rates in Women, Selected Countries, 1980–2010 (2015) (0)
- Additional file 2: of The determinants of home and nursing home death: a systematic review and meta-analysis (2016) (0)
- Factors Associated with Health Care Resource Utilization in Myeloproliferative Neoplasms: A Population-Based Cost Study (2019) (0)
- Is care coordination associated with improved care quality for comorbid conditions in cancer survivors (2012) (0)
- Mo1964 A Cluster Randomized Trial of Directly Mailed gFoBT Kits to Previous Responders Being Recalled for Screening (2015) (0)
- Patterns of initial treatment and survival among older patients with glioblastoma multiforme: Evidence from SEER-Medicare data (2007) (0)
- Characterizing The Utilization of The Trillium Drug Program by An Oncology Patient Population (2017) (0)
- Abstract P1-10-09: Access to HER2 Testing in Early Stage Breast Cancer (ESBC) in a Single Payor, Public Healthcare System — Ontario (ON), Canada (2010) (0)
- Phase I study of S-1 administrated for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer (AUGIC) (2005) (0)
- Towards international standardisation of the comorbidity index from hospital data in lung cancer patients (2017) (0)
- Does the dose of leucovorin (LV) matter with 5-fluorouracil (5FU) in colorectal cancer (CRC)? (2016) (0)
- The effect of vasectomy reversal on prostate cancer risk: International meta-analysis of 684,660 men with vasectomies. Authors: (2018) (0)
- Non-small cell lung cancer: Assessment of methodologies to combine survival curves in meta-analysis. (1998) (0)
- Opioid use in long term cancer survivors. (2018) (0)
- Disparities in all-cause mortality among younger commercially insured women with metastatic breast cancer. (2016) (0)
- Additional file 3: of The determinants of home and nursing home death: a systematic review and meta-analysis (2016) (0)
- The Association of Dyslipidemia with the Development of Chronic Lymphocytic Leukemia: A Population-Based Study (2015) (0)
- Time trends in opioid use in cancer and noncancer patients: Observations from administrative data. (2016) (0)
- An Evaluation of Linked Administrative Data for Cancer Clinical Trial Economic Analysis (2020) (0)
- 1019 The impact of immigration status and ethnicity and cancer outcomes in Ontario, Canada (2015) (0)
- American Society of Clinical Oncology third quality care symposium. (2015) (0)
- Diagnostic Patterns of Care and Outcomes for Patients with Chronic Lymphocytic Leukemia in the Surveillance, Epidemiology, and End-Results (SEER)-Medicare Database (2008) (0)
- PCN158 Adherence to Human Epidermal Growth Factor Receptor-2 (HER2) Testing & Adjuvant Trastuzumab Treatment Guidelines in a Canadian Province (2012) (0)
- Relationship between time to trastuzumab initiation and overall survival among young commercially insured women with metastatic breast cancer. (2016) (0)
- The impact of immigration status on cancer outcomes in Ontario, Canada. (2016) (0)
- Discussions about end-of-life care planning between physicians and patients with stage IV lung or colorectal cancer. (2011) (0)
- treatment, but it does influence the kind of treatment received. (2006) (0)
- Economic impacts of care by high-volume providers for noncurative esophagogastric cancer: A population-based analysis. (2020) (0)
- The Anemia Workup in Current Clinical Practice: Results From a Survey of Primary Care Physicians (2011) (0)
- 183 Gemcitabine (G), VP16 (V) and cisplatin (P). Phase I study in small cell lung cancer (SCLC) (1997) (0)
- Chemotherapy choice in advanced pancreatic cancer: What patient and disease factors influence prescription patterns? (2018) (0)
- Costs after incident breast cancer diagnosis among high-deductible health plan members. (2019) (0)
- Great expectations: patients’ preferences for clinically significant results from genomic sequencing (2023) (0)
- Epidemiology: How to Appraise the Ablation Literature Critically (2005) (0)
- Active identification of patients appropriate for palliative care: Impact on use of palliative care and home care resources. (2018) (0)
- Impact of high deductible insurance on out-of-pocket cost burden in breast cancer. (2018) (0)
- Rescue following pancreaticoduodenectomy: a multi-center observational population-based analysis (2017) (0)
- End-of-life care for Medicare beneficiaries with ovarian cancer: Evaluation of intensity and rate of hospitalizations. (2013) (0)
- Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall Survival. (2023) (0)
- Microsatellite instability is associated with favorable outcomes in patients with colorectal cancer (2000) (0)
- Lymph node retrieval rates affect adjuvant chemotherapy (AC) utilization for stage II colon cancer at the National Comprehensive Cancer Network (NCCN) institutions. (2008) (0)
- Cancer quality alliance proceedings: caring beyond cancer. (2009) (0)
- Diagnostic Delays and Survival for Medicare Patients with Chronic Myeloid Leukemia in the Pre-Imatinib Era. (2009) (0)
- Treatment patterns and costs associated with acute myeloid leukemia in the elderly: A population-based analysis (2004) (0)
- Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study (2018) (0)
- Influenza V accination i n E lderly P atients W ith A dvanced Colorectal C ancer (2003) (0)
- Prologue: Surviving Cancer: SEER Statistics (2014) (0)
- Incidence of diabetes among patients with colorectal cancer. (2014) (0)
- Cost-effectiveness of second-line ipilimumab for metastatic melanoma: A real-world population-based cohort study of resource utilization. (2023) (0)
- Best Oral Abstract: Development of health-state classification system for a new breast cancer–specific preference-based measure: the BREAST-Q utility module (2020) (0)
- Introduction to the ASCO Quality Care Symposium. (2013) (0)
- Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab. (2016) (0)
- A weighted criterion-based approach to value assessment of oncology drugs. (2019) (0)
- Reply to E. Warner (2012) (0)
- Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial (2019) (0)
- Impact of high-deductible insurance on breast cancer care among lower-income women. (2018) (0)
- Synchronous anal canal carcinoma in a heterosexual couple (2018) (0)
- Abstract A053: Association between socioeconomic status and access to specialized cancer consultation and treatment among advanced gastrointestinal cancers (2020) (0)
- Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: A population-based cohort study. (2023) (0)
- Quality o f N on-Breast C ancer H ealth M aintenance A mong Elderly B reast C ancer S urvivors (2003) (0)
- Use of QT interval prolonging drugs (QT drugs) and electrocardiogram (ECG) monitoring in patients (pts) receiving first-line anti-cancer systemic therapy (tx): A population-based analysis. (2018) (0)
- Provider Volume and Outcomes Following Prostate Brachytherapy (2007) (0)
- Gender Differences in the Receipt of Treatment for Bladder Cancer (2006) (0)
- Does Higher Volume Lead to Higher Performance? The Impact of Hospital Volume on 90-Day Postoperative Outcomes after Pancreaticoduodenectomy (2016) (0)
- Predictors of adherence among post-menopausal women receiving adjuvant endocrine therapy for breast cancer in Ontario, Canada (2019) (0)
- The Effect of Specialized Palliative Care on End-of-Life Care Intensity in AYAs with Cancer. (2022) (0)
- An evaluation of administrative data linkage for measurement of real-world outcomes of large clinical panel sequencing for advanced solid tumors. (2020) (0)
- Temporal trends in first-line chemotherapy treatment among elderly stage IIIB/IV non-small cell lung cancer (NSCLC) patients in the United States: Evidence from SEER-Medicare data (2007) (0)
- Introduction; Oral Care in Advanced Disease; Supportive Care for the Renal Patient; Handbook of Opioid Bowel Syndrome:Oral Care in Advanced Disease.;Supportive Care for the Renal Patient.;Handbook of Opioid Bowel Syndrome. (2006) (0)
- Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer (2016) (0)
- MP-3.15: Patterns of Care for Radical Prostatectomy in the United States from 2003-2005 (2008) (0)
- Impact of patient and physician factors on oncologists' recommendations for adjuvant chemotherapy in stage III colon cancer. (2006) (0)
- 2 How to Appraise the Ablation Literature Critically (2010) (0)
- Toxicity of high-dose interferon for high-risk melanoma in Ontario: A population-based study of health services use. (2017) (0)
- Population-Based Health Care Cost Estimates Related to Non-Hodgkin Lymphoma (NHL) (2011) (0)
- Reply to M.A. Hoffman et al (2012) (0)
- Impact of Follow-Up Colonoscopy Quality on Canadian Colorectal Cancer Outcomes and Costs (2018) (0)
- A Severity Adjustment System Using Electronic Data Sources for Predicting Financial Outcomes for Oncology (2000) (0)
- Home care utilization and costs in stage IV lung cancer: a Canadian public payer experience (2014) (0)
- Are We Choosing Wisely in Lymphoma? Excessive Use of Surveillance CT Imaging in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Long-Term Remission (2016) (0)
- Barriers in providing breast and colorectal cancer survivorship care: Perceptions of U.S. primary care physicians (PCPs) and medical oncologists (MOs). (2011) (0)
- The effect of race on recommendation and acceptance of surgical resection for non-metastatic non-small cell lung cancer (NSCLC) (2004) (0)
- Additional file 1: of The determinants of home and nursing home death: a systematic review and meta-analysis (2016) (0)
- Systemic treatment patterns in small bowel and appendiceal adenocarcinomas (SBA and AA): A population-based study. (2016) (0)
- RCD20223 1054..1064 (2009) (0)
- Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population (2013) (0)
- Primary Care Referrals for Suspected Hematologic Malignancies: Incidence, Factors Affecting Choice of Specialist, and Flow of Referral Information. (2010) (0)
- Additional file 7: of Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study (2018) (0)
- Directly Mailing gFOBT Kits to Previous Responders Being Recalled for Colorectal Cancer Screening Increases Participation (2019) (0)
- Synchronous anal canal carcinoma in a heterosexual couple (2018) (0)
- Quality of life drives patients’ preferences for secondary findings from genomic sequencing (2020) (0)
- E20. Reimbursement policies, research, and prescribing practices: The United States perspective (2005) (0)
- Opportunities for improved end-of-life (EOL) care for adult patients with advanced cancer: Results of a longitudinal assessment of care provided by Quality Oncology Practice Initiative (QOPI) participants. (2013) (0)
- Stage at diagnosis, treatment, and survival among US- and foreign-born Asian and Pacific Islanders with gastric cancer (2007) (0)
- Physician Agency and Patient Survival - eScholarship (2016) (0)
- Methods to improve the estimation of time‐to‐event outcomes when data is de‐identified (2018) (0)
- EP-1387: Time Trends In Opioid Use In Cancer Patients with Pain: Observations from Administrative Data (2017) (0)
- LBA87 A pragmatic cluster-randomized trial of ambulatory toxicity management in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer (AToM) (2020) (0)
- Predictors of complications following prostate brachytherapy. (2016) (0)
- Does prognostic uncertainty affect discussions of prognosis? Lessons from a survey of hematologic oncologists. (2017) (0)
- Temporal treatments and outcomes following acute myocardial infarction among cancer survivors: A population-based study, 1995-2013. (2017) (0)
- Cancer stage at diagnosis, treatment, and survival among US- and foreign-born Asians and Pacific Islanders with gastric cancer (2007) (0)
- The PROVIEW+ tool: Developing and validating a tool to predict risk of poor performance status and severe symptoms in cancer patients over time. (2021) (0)
- Are we choosing wisely? Operationalizing Choosing Wisely in the Ontario cancer system. (2017) (0)
- A reader's guide totheevaluation of screening studies (2017) (0)
- Burden of out-of-pocket spending among high-deductible health plan members with metastatic breast cancer. (2017) (0)
- Cardiac care after myocardial infarction in cancer survivors: A population-based study. (2015) (0)
- PCN43 THE ASSOCIATION OF TUMOR HISTOLOGY WITH FIRST-LINE TREATMENT AND LIFETIME MEDICAL-CARE COSTS AMONG ELDERLY STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH COMMONLY USED DOUBLET THERAPIES AMONG (2008) (0)
- Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer (0)
- Real-world cost-effectiveness of pertuzumab (P) with trastuzumab + chemo (T+Chemo) in patients (pts) with metastatic breast cancer (MBC): A population-based retrospective cohort study by the Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) collaboration. (2021) (0)
- The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada (2021) (0)
- Second Annual ASCO Quality Care Symposium. (2014) (0)
- Beyond the dollar: Influence of sociodemographic marginalization on survival and adjuvant therapy following resection of pancreatic cancer (2016) (0)
- 216 The Impact of Routine ESAS Use on Emergency Department Visits and Hospitalizations: A Population-Based Retrospective Matched Cohort Study (2019) (0)
- Does the presence of an intact primary increase the risk of nonelective colorectal surgery in patients treated with bevacizumab? (2020) (0)
- Incidence of minimally invasive colorectal cancer (CRC) surgery in patients treated at NCCN institutions (2016) (0)
- Care of the Cancer Survivor (2008) (0)
- Rates of postoperative interventions following pancreaticoduodenectomy for pancreatic cancer (2016) (0)
- Development and validation of a risk prediction model for poor performance status and severe symptoms among cancer patients. (2020) (0)
- Quantifying Costs of Medical Personnel Involved with Radiation therapy Using Administrative Databases. (2015) (0)
- International meta-analysis of 684,660 men with vasectomies: a study utilising the International Population Data Linkage Network (2018) (0)
- Predictors and effect of delay in initiation of radiation therapy (RT) after breast-conserving surgery (BCS) in elderly women (2008) (0)
- 192P The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada (2020) (0)
- Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes (2023) (0)
- Phase I study of geWtinib, irinotecan, 5-Xuorouracil and leucovorin in patients with metastatic colorectal cancer (2007) (0)
- ArticlesEffect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients (2006) (0)
- Comprar Patient Surveillance After Cancer Treatment | Johnson, Frank E. | 9781603279680 | Springer (2010) (0)
- The effect of hospital racial composition on obtaining surgery for non-metastatic small cell lung cancer (NSCLC) (2005) (0)
- Four Years Running: The ASCO Quality Care Symposium. (2016) (0)
- Comparison of outcomes in a population-based cohort of women with metastatic breast cancer receiving anti-HER2 therapy with clinical trial outcomes. (2019) (0)
- Cetuximab (Cmab) plus irinotecan (I) versus panitumumab (Pmab) in patients with refractory metastatic colorectal cancer (mCRC) in Ontario (2016) (0)
- Patient-reported symptom severity following curative-intent resection for pancreas adenocarcinoma (2019) (0)
- Reply to K. Kajiwara et al. concerning “Caregiver bereavement outcomes in advanced cancer: associations with quality of death and patient age” (2022) (0)
- PCN22 FIRST-LINE TREATMENT AND LIFETIME MEDICAL-CARE COSTS AMONG ELDERLY STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH COMMONLY USED DOUBLET THERAPIES (2007) (0)
- Patterns of chemotherapy for recurrent pancreatic cancer following resection: A population-level analysis (2016) (0)
- Additional file 4: of The determinants of home and nursing home death: a systematic review and meta-analysis (2016) (0)
- First Two Years of Health System Resources and Costs Following a Stage Defined Breast Cancer Diagnosis: A Population Based Approach (2014) (0)
- Use of Instrumental Variable Analyses for Evaluating Comparative Effectiveness in Empirical Applications of Oncology: A Systematic Review. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Craig C. Earle?
Craig C. Earle is affiliated with the following schools:
